THE JOURNAL OF PEDIATRICS
Children’s Hospital Medical Center, MLC-3021 3333 Burnet Ave.
Cincinnati, OH 45229-3039
513-636-7140 FAX: 513-636-7141
For more information or to obtain a copy of the article, contact: Becky Lindeman, 513-636-7140, firstname.lastname@example.org.
Embargoed until 12:01 AM ET, March 10, 2016
ADHD or Just Immature?
Cincinnati, OH, March 10, 2016 -- Attention-deficit hyperactivity disorder (ADHD) is typically diagnosed in childhood and manifests as an inability to sustain attention and control activity levels and impulse control. Some reports have indicated a prevalence of up to 15% in Western countries. Although the causes of ADHD are still unknown, a new study scheduled for publication in The Journal of Pediatrics found that a child’s age at school entry may have an effect on the diagnosis of ADHD.
Dr. Mu-Hong Chen and colleagues from Taipei and Taoyuan, Taiwan, examined cohort data from 378,881 children ages 4-17 years from 1997 to 2011 and evaluated the prevalence of being given a diagnosis of ADHD and/or prescribed ADHD medication. Using the Taiwanese annual cut-off birthdate of August 31 for school enrollment, the researchers compared the youngest children in a grade (those born in August) with the oldest (those born in September) and assessed whether age was associated with being diagnosed with ADHD and/or being medicated.
When looking at the database as a whole, children born in August were more likely to be diagnosed with ADHD and/or receive ADHD medication than those born in September. When broken down and analyzed according to age, only preschool or elementary school-aged children born in August had an increased risk of being diagnosed with ADHD and receiving ADHD medication. However, adolescents born in August did not have an increased risk of ADHD diagnosis. This may imply that increasing age and maturity lessens the impact of birth month on ADHD diagnoses.
Worldwide, the number of children and adolescents being diagnosed with ADHD or receiving a prescription for ADHD has significantly increased. Evidence shows that relative age, which may be a proxy of neurocognitive ability, may increase the likelihood of ADHD diagnosis and medication. According to Dr. Chen, “Our findings emphasize the importance of considering the age of a child within a grade when diagnosing ADHD and prescribing medication to treat ADHD.”
NOTES FOR EDITORS
“Influence of Relative Age on Diagnosis and Treatment of ADHD in Taiwanese Children,” by Mu-Hong Chen, M.D., Wen-Hsuan Lan, M.D., Ya-Mei Bai, M.D., PH.D., Kai-Lin Huang, M.D., Tung-Ping Su, M.D., Shih-Jen Tsai, M.D., Cheng-Ta Li, M.D., Ph.D., Wei-Chen Lin, M.D., Wen-Han Chang, M.Sc., Tai-Long Pan, PhD., Tzeng-Ji Chen, M.D., PH.D., and Ju-Wei Hsu, M.D., appears in The Journal of Pediatrics (www.jpeds.com), DOI 10.1016/j.jpeds.2016.02.012, published by Elsevier.
ABOUT THE JOURNAL OF PEDIATRICS
The Journal of Pediatrics is a primary reference for the science and practice of pediatrics and its subspecialties. This authoritative resource of original, peer-reviewed articles oriented toward clinical practice helps physicians stay abreast of the latest and ever-changing developments in pediatric medicine. The Journal of Pediatrics is ranked 6th out of 117 pediatric medical journals (2013 Journal Citation Reports®, published by Thomson Reuters). URL: www.jpeds.com
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Elsevier Research Intelligence (www.elsevier.com/research-intelligence) and ClinicalKey (www.clinicalkey.com) — and publishes nearly 2,500 journals, including The Lancet (www.thelancet.com) and Cell (www.cell.com), and over 25,000 book titles, including a number of iconic reference works.
Elsevier is part of RELX Group (www.relxgroup.com), a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com